ストックスクリーナーアプリを入手
21.91
0.57%
0.12
前日終値:
$21.79
開ける：
$21.89
24時間の取引高:
39,298
Relative Volume:
0.14
時価総額：
$12.79B
収益：
$20.87B
当期純損益:
$715.19M
株価収益率:
26.86
EPS:
0.8156
ネットキャッシュフロー:
$2.10B
1週間 パフォーマンス:
+2.79%
1か月 パフォーマンス:
+4.31%
6か月 パフォーマンス:
+2.31%
1年 パフォーマンス:
+11.53%
1日の値動き範囲:
$21.85
$22.00
1週間の範囲:
$21.42
$22.20
52週間の値動き範囲:
$17.93
$22.76
Fresenius Medical Care Ag Adr Stock (FMS) Company Profile
FMS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| FMS | 21.90 | 12.79B | 20.87B | 715.19M | 2.10B | 0.8156 |
| HCA | 323.13 | 83.79B | 69.62B | 5.93B | 5.88B | 20.33 |
| THC | 143.99 | 14.83B | 20.97B | 3.13B | 2.39B | 4.33 |
| DVA | 162.71 | 13.19B | 12.67B | 827.68M | 1.42B | 5.03 |
| UHS | 190.29 | 13.03B | 15.42B | 1.03B | 956.84M | 9.53 |
Fresenius Medical Care Ag Adr Stock (FMS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-01-08 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2023-11-24 | アップグレード | HSBC Securities | Reduce → Hold |
| 2023-11-17 | アップグレード | Societe Generale | Hold → Buy |
| 2023-08-14 | ダウングレード | UBS | Buy → Neutral |
| 2023-08-01 | 再開されました | Citigroup | Neutral |
| 2023-07-12 | 開始されました | Goldman | Buy |
| 2023-03-07 | 開始されました | Bernstein | Mkt Perform |
| 2023-01-03 | ダウングレード | Jefferies | Buy → Underperform |
| 2022-10-26 | ダウングレード | Deutsche Bank | Hold → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-10-10 | ダウングレード | Jefferies | Buy → Hold |
| 2022-06-27 | アップグレード | Jefferies | Underperform → Buy |
| 2022-02-11 | ダウングレード | Jefferies | Hold → Underperform |
| 2021-11-23 | 開始されました | HSBC Securities | Hold |
| 2021-11-11 | アップグレード | Jefferies | Underperform → Hold |
| 2021-02-04 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-02-03 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2020-05-20 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-21 | アップグレード | Jefferies | Hold → Buy |
| 2019-06-20 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-10 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-10-26 | アップグレード | UBS | Neutral → Buy |
| 2018-08-28 | アップグレード | HSBC Securities | Hold → Buy |
| 2018-07-05 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2018-01-04 | アップグレード | UBS | Sell → Neutral |
| 2017-12-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2016-11-01 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2016-09-06 | アップグレード | Citigroup | Neutral → Buy |
| 2016-07-08 | アップグレード | Jefferies | Underperform → Hold |
| 2016-01-04 | アップグレード | JP Morgan | Neutral → Overweight |
| 2015-11-04 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2015-09-03 | アップグレード | Goldman | Neutral → Buy |
| 2015-08-13 | ダウングレード | Societe Generale | Buy → Hold |
| 2015-07-31 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2013-08-02 | 繰り返されました | Feltl & Co. | Hold |
| 2013-01-14 | アップグレード | HSBC Securities | Neutral → Overweight |
すべてを表示
Fresenius Medical Care Ag Adr (FMS) 最新ニュース
Blood Recovery Machine Market is expected to reach revenue of USD 4,277.4 Mn by 2033, at 5.9% CAGR: Dimension Market Research. - GlobeNewswire Inc.
Fresenius Medical Care Earnings: Margin Expansion Boosts 2024 Profit Outlook Toward Top End of Goal - Morningstar
Fresenius Medical Care ADR earnings beat by $0.35, revenue fell short of estimates - Investing.com India
Germany Home Healthcare Market Forecast Report 2024-2032 - GlobeNewswire Inc.
Weekly Upgrades and Downgrades - InvestorPlace
2024 Healthcare Stocks List | Updated Daily - Sure Dividend
Saudi Arabia Generic Pharmaceutical Products Market Report 2024-2031, Featuring Profiles of Key Players - GlobeNewswire Inc.
FMS Stock Rides On Diversified Portfolio And Restructuring Initiatives - Barchart
Canada Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar
The Best Healthcare Stocks to Buy - Morningstar
Expert Call - Fresenius Medical Care
Earnings call: Fresenius Medical Care sees steady progress in Q2 - Investing.com
Earnings call: Fresenius Medical Care confirms outlook, reports growth - Investing.com
Fresenius Medical Care Aims to Improve Its Margins Substantially - Morningstar
Fresenius Medical Care delivers continued operating income improvements in the second quarter of 2024 - Fresenius Medical Care
UK Clinical Laboratory Service Market Size & Outlook, 2030 - Grand View Research
Singapore Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Italy Home Healthcare Market Size & Outlook, 2023-2030 - Grand View Research
Fresenius Medical Care celebrates 50th anniversary of St. Wendel site - Fresenius Medical Care
Kidney Transplant Market to Grow at a 3.3% CAGR from 2024 to 2034, Fueled by Healthcare Spending and Renal ... - GlobeNewswire Inc.
Fresenius Medical Care: Significant Upside Remains (NYSE:FMS) - Seeking Alpha
Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com - Defense World
Fresenius Medical Care AG (NYSE:FMS) Shares Acquired by GAMMA Investing LLC - Defense World
Fresenius Medical Care Ag Adr (FMS) 財務データ
収益
当期純利益
現金流量
EPS
2.31%
0.80%
大文字化:
|
ボリューム (24 時間):